MedPath

Tegafur,Gimeracil and Oteracil Potassium

Generic Name
Tegafur,Gimeracil and Oteracil Potassium

Overview

No overview information available.

Background

No background information available.

Indication

用于不能切除的局部晚期或转移性胃癌。 用于治疗成人胆道癌【日本PMDA已批准;《胆管癌诊断与治疗-外科专家共识》】。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2011/06/20
Phase 2
Completed
2011/02/08
Phase 1
Completed
2011/02/08
Phase 1
Completed
Kansai Hepatobiliary Oncology Group
2011/01/28
Phase 3
Terminated
2010/10/25
Phase 1
UNKNOWN
2010/09/10
Phase 3
UNKNOWN
Sun Yat-sen University
2010/08/12
Phase 2
UNKNOWN
Peking University Cancer Hospital & Institute
2010/08/04
Phase 1
Completed
2010/05/24
Phase 1
Completed
National Health Research Institutes, Taiwan
2010/02/24
Phase 2
UNKNOWN
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

Singapore Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.
Online

No Singapore products found

No Singapore products found for this drug

China Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No China products found

No China products found for this drug

Australia Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No Australia products found

No Australia products found for this drug

© Copyright 2025. All Rights Reserved by MedPath